Coronary CTA on Asymptomatic Patients Provides Little to No Clinical Benefit

Asan Medical Center research team finds increasing rate of coronary CTAs on domestic asymptomatic patients but little subsequent diagnostic, survival benefit


Aspirin Alone Better for Post-TAVI Patients not on Anticoagulation: POPular TAVI

Study comparing aspirin+clopidogrel vs. aspirin shows aspirin alone reduced risk of all bleeding with no increased thrombotic risk for post-TAVI patients not on oral anticoagulation


2nd SGLT-2 Inhibitor Scores in HF as Empagliflozin Reduces Hospitalization, CV Death in HFrEF

EMPEROR-Reduced: diabetes drug empagliflozin shows significant CV, renal benefits in HFrEF regardless of diabetes status

News | ACT Program

1st Virtual ACT Program Held

The "A"san Medical Center Interventional "C"ardiology "T"raining Program (hereinafter referred to as ACT Program) was successfully held online for the first time for two days on June 19th (Fri) and 20th (Sat) by attracting approximately 600 participants.

News | TCTAP & AP VALVES 2020

Choice of Stent Platforms in HBR Patients - Insights from the ONYX-ONE Trial

August 8th, Highlight Session of TCTAP & AP VALVES 2020 VIRTUAL